Medicinal – Page 164

Extracellular Biosynthesis, Characterization and Antimicrobial Activity of Silver Nanoparticles Synthesized by Filamentous Fungi

mycolabadmin

Researchers used three types of fungi to naturally create tiny silver particles that can kill harmful bacteria and fungi. These particles were much smaller than the width of a human hair and proved especially effective against dangerous bacteria like those causing hospital infections and Candida yeast infections. This green manufacturing method is safer for the environment than traditional chemical approaches and could help address the growing problem of drug-resistant infections.

Increasing postgraduate medical mycology research dissertations at Uganda’s higher institution of learning

mycolabadmin

A study from Makerere University in Uganda found that funding has significantly boosted research on fungal diseases among graduate students. The number of students focusing on medical mycology jumped from 16% to 40% between 2023 and 2024, with more advanced laboratory techniques being used. The research focused on serious fungal infections like cryptococcal meningitis, which particularly affects people with HIV/AIDS. The university’s creation of a collaborative research group helped students work together and complete their projects on time.

Schizophyllum radiatum: An uncommon culprit of invasive fungal rhinosinusitis in an immunocompetent patient – A case report from India

mycolabadmin

A 32-year-old healthy woman in India developed a serious fungal infection in her sinuses caused by an extremely rare fungus called Schizophyllum radiatum. Standard laboratory tests could not identify the fungus due to its unusual characteristics, so doctors used advanced DNA sequencing to confirm the diagnosis. After surgery to remove the infected material and treatment with antifungal medication, the patient fully recovered, marking this as likely the first documented case of this type of infection in India.

Tracing the Origin and Evolution of the Fungal Mycophenolic Acid Biosynthesis Pathway

mycolabadmin

Scientists studied how different fungal species produce mycophenolic acid, a drug used to prevent transplant rejection in millions of patients worldwide. By analyzing the genomes of many fungal species, they found that only a few fungi can make this important drug, and they discovered that these fungi have different ways of protecting themselves from being poisoned by their own medicine. This research helps us understand how fungi evolve to produce valuable medicines and could lead to better ways to produce immunosuppressants.

Mixed Infection With Aspergillosis and Actinomycosis in the Maxillary Sinus: A Case Report

mycolabadmin

A 74-year-old woman had a purulent nasal discharge for 1.5 years caused by two different infections occurring simultaneously in her maxillary sinus: aspergillosis (a fungal infection) and actinomycosis (a bacterial infection). Imaging initially suggested only a fungal ball, but pathological examination revealed both organisms were present. The patient was successfully treated with surgical removal of the infected material followed by antibiotic therapy.

Virulence factors of Candida spp. isolated from COVID-19 patients: hydrolytic enzyme activity and biofilm formation

mycolabadmin

During the COVID-19 pandemic, many hospitalized patients developed fungal infections caused by Candida yeasts alongside their coronavirus infection. Researchers studied 71 Candida samples from COVID-19 patients to understand how these fungi cause disease by examining three damaging enzymes they produce and their ability to form protective biofilm layers. The findings showed that these fungi are highly virulent, producing strong enzyme activity that helps them invade tissues and resist treatment, which helps explain why these infections are particularly dangerous in COVID-19 patients.

Deep Fungal Infection of the Skin with Two Rare Fungi in a Dog Being Treated with Immunosuppressant Therapy: A Case Report

mycolabadmin

An 8-year-old dog receiving long-term immunosuppressive medication for brain inflammation developed rare fungal skin infections caused by two unusual fungi not previously reported together in veterinary medicine. Diagnosis required multiple tests including tissue samples, staining techniques, and genetic testing. Despite treatment with antifungal medications and careful adjustment of immunosuppressive drugs, the infections did not improve, highlighting the difficult balance between fighting infections and controlling the underlying immune disease.

Favorable outcome of Lasiodiplodia theobromae keratomycosis: a clinical case and systematic review

mycolabadmin

A 74-year-old farmer developed a serious fungal eye infection caused by Lasiodiplodia theobromae, a rare tropical fungus. Instead of requiring eye surgery, the patient was successfully treated with a combination of two antifungal medications applied as eye drops and taken orally for eight weeks. This case is significant because it’s the first documented successful medical treatment of this particular fungal infection, highlighting the importance of quick diagnosis and avoiding corticosteroid eye drops that can worsen fungal infections.

Deep learning application to hyphae and spores identification in fungal fluorescence images

mycolabadmin

Researchers developed an artificial intelligence system that can automatically identify fungal infections in microscope images as accurately as experienced doctors. The system uses two different AI models working together to spot fungal spores, thread-like hyphae, and mycelium in fluorescence images. This technology could significantly reduce the time doctors spend analyzing samples and help ensure more accurate diagnoses, especially in hospitals with fewer experienced specialists.

Invasive Fungal Disease is Rare in Multiple Myeloma Patients Treated with BCMA CAR-T Therapy

mycolabadmin

Researchers studied patients with multiple myeloma who received a new type of cancer treatment called BCMA CAR-T cell therapy. While this powerful therapy can sometimes increase infection risk, the study found that serious fungal infections occurred in only a small percentage of patients (1.7%). However, when these fungal infections did occur, they were often severe and potentially life-threatening, particularly in patients who experienced significant side effects from the therapy.

Research Topic: Medicinal